Cargando…
Poor pregnancy outcome after octreotide treatment during pregnancy for familial hyperinsulinemic hypoglycemia: a case report
BACKGROUND: Late familial hyperinsulinemic hypoglycemia is characterized by recurrent episodes of hypoglycemia and an inappropriate insulinemic response. Treatment with octreotide (somatostatin analogue) reduces the prevalence of clinical significant hypoglycemia and might be beneficial during pregn...
Autores principales: | Skajaa, Gitte O, Mathiesen, Elisabeth R, Iyore, Elisabeth, Beck-Nielsen, Henning, Jimenez–Solem, Espen, Damm, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4242601/ https://www.ncbi.nlm.nih.gov/pubmed/25404386 http://dx.doi.org/10.1186/1756-0500-7-804 |
Ejemplares similares
-
Octreotide therapy and restricted fetal growth: pregnancy in familial hyperinsulinemic hypoglycemia
por: Geilswijk, Marianne, et al.
Publicado: (2017) -
Octreotide-Treated Diabetes Accompanied by Endogenous Hyperinsulinemic Hypoglycemia and Protein-Losing Gastroenteropathy
por: Takahashi, Nobuhiko, et al.
Publicado: (2011) -
Successful Treatment of Postprandial Hyperinsulinemic Hypoglycemia After Billroth-II Gastrojejunostomy Using Octreotide
por: Hasebe, Masashi, et al.
Publicado: (2023) -
Hyperinsulinemic Hypoglycemia – The Molecular Mechanisms
por: Nessa, Azizun, et al.
Publicado: (2016) -
A Case of Persistent Hyperinsulinemic Hypoglycemia of Infancy Successfully
Managed with Subcutaneous Octreotide Injection and Nocturnal Intravenous Glucose
Supply
por: Murakami, Mari, et al.
Publicado: (2007)